万青松,李莉,谢红萍,欧继红,杨波.替米沙坦对2型糖尿病肾病患者蛋白尿的影响.[J].中南医学科学杂志.,2010,(1):.
替米沙坦对2型糖尿病肾病患者蛋白尿的影响
Effect of Proteinuria in Patients With Type 2 Diabetic Nephropathy by Telmisartan
  
DOI:
中文关键词:  替米沙坦  2型糖尿病肾病  洛沙坦  蛋白尿  
英文关键词:telmisartan  type 2 diabetic nephropathy  losartan  proteinuria  
基金项目:
万青松  李莉  谢红萍  欧继红  杨波
南华大学第一附属医院肾内科;湖南环境生物职业技术学院护理学院;
摘要点击次数: 770
全文下载次数: 0
中文摘要:
      目的探讨替米沙坦对2型糖尿病肾病患者蛋白尿的影响。方法36例2型糖尿病肾病患者,随机平均分为替米沙坦组和洛沙坦组,在常规药物治疗的基础上,分别予替米沙坦80 mg/天及洛沙坦100 mg/天治疗,测量患者血压、24 h尿蛋白定量及生化指标。结果30周后,两组患者血压、24 h尿蛋白定量均明显下降,而血糖、血脂、肾小球滤过率(GFR)无明显变化,替米沙坦组与洛沙坦组比较,24 h尿蛋白定量下降更显著,而血压下降差别不大。结论对于2型糖尿病肾病,替米沙坦比洛沙坦有更显著降尿蛋白的作用。
英文摘要:
      Objective To investigate the effect of proteinuria of telmisartan on type 2 diabetic nephropathy. Methods In addition to ongoing treatment,thirty six type 2 diabetic patients with nephropathy were randomly devided into telmisartan group and losartan group,which were treated with telmisartan 80 mg once daily and losartan 100 mg once daily respectively,and blood pressure,24 h proteinuria and biochemical parameters were measured. Results After thirty weeks,24 h proteinuria and blood pressure decreased signific...
查看全文  查看/发表评论  下载PDF阅读器
关闭
function PdfOpen(url){ var win="toolbar=no,location=no,directories=no,status=yes,menubar=yes,scrollbars=yes,resizable=yes"; window.open(url,"",win); } function openWin(url,w,h){ var win="toolbar=no,location=no,directories=no,status=no,menubar=no,scrollbars=yes,resizable=no,width=" + w + ",height=" + h; controlWindow=window.open(url,"",win); } &et=FF4EC6B96077DFE74217525FDDEEEF858EA8BB088D64C252B979A1B4DE1D9D1CE4DDD8163E5109B5CFFA6B149E6417EB0E2E3F739FC6EAFA7D1AA18F251A41FA96CC8E4F801B9A909E471D90E9F791FA08C33117DA08ADB0&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=BB33F1C95224820A&jid=6A20DF2A798996E24F064D5ECF83A153&yid=140ECF96957D60B2&aid=61573853&vid=&iid=CA4FD0336C81A37A&sid=&eid=&fileno=20100130&flag=1&is_more=0">